Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2008, Vol. 13 ›› Issue (1): 103-106.

Previous Articles     Next Articles

Experimental study on anti-tumor effect of chitosan sulfate in mice

HE Kang1, FENG You-hui1, AI Chun-mei2   

  1. 1Department of Physiological Science, Guangdong Medical College, Zhanjiang 524023, Guangdong, China;
    2Guangdong Key Laboratory for Research and Development of Natural Drugs, Zhanjiang 524023, Guangdong, China
  • Received:2007-08-15 Revised:2007-12-12 Online:2008-01-26 Published:2020-10-13

Abstract: AIM: To investigate the anti-tumor effects of chitosan sulfate in mice. METHODS: 80 mice were divided into control group, 5-FU treatment group and Chitosan sulfate treatment group (200 mg/kg and 100 mg/kg). Different doses of Chitosan were intraperitoneally injected into mice with sarcoma 180 and EAC cancer respectively for 10 days. The tumor inhibiting rate, the weight index of important organ and life prolongation were calculated. RESULTS: The tumor inhibiting rate of high dose, low dose of Chitosan sulfate and 5-FU were 38. 67 %, 30.19 %, 43. 27 %, life prolongation of high dose, low dose of Chitosan sulfate and 5-FU were 65. 38 %, 69. 23 %, 54. 93 %, Compare with control and 5-FU group, the indexes of thymus in high dose and low dose of Chitosan sulfate were significantly increased (P<0.05). CONCLUTIONS: Chitosan sulfate shows significant anti-tumor effects on sarcoma-180 and can prolong the life of mice with EAC cancer. Such effects may be owe to improvement of body immunity.

Key words: chitosan sulfate, anti-tumor, sarcoma-180, EAC cancer

CLC Number: